Membrane-destabilizing ionizable phospholipids: Novel components for organ-selective mRNA delivery and CRISPR-Cas gene editing.
Signal transduction and targeted therapy, 6(1): 206 PMID 34035211 DOI 10.1038/s41392-021-00642-z
Abstract
This article has no abstract in PubMed.